NIVIEN THERAPEUTICS
Nivien Therapeutics developed the first small molecule inhibitors of the Hippo signaling pathway. Read the Nivien story in The Washington Post: https://www.washingtonpost.com/national/health-science/heres-what-happened-when-i-tried-to-develop-a-new-drug-for-a-deadly-cancer/2019/01/11/
NIVIEN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.nivientherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud Sectigo SSL
Current Employees Featured
Nikita Shah
Nikita Shah President & CFO @ Nivien Therapeutics President & CFO 2017-08-01
W. Ken Fang
W. Ken Fang SVP, Medicinal Chemistry @ Nivien Therapeutics SVP, Medicinal Chemistry
Founder
Dharmendra Singh
Nathaniel Brooks Horwitz
Nikita Shah
W. Ken Fang
Investors List
Third Kind Venture Capital
Third Kind Venture Capital investment in Seed Round - Nivien Therapeutics
SOSV
SOSV investment in Seed Round - Nivien Therapeutics
IndieBio
IndieBio investment in Seed Round - Nivien Therapeutics
Newest Events participated
Participated in IndieBio San Francisco Demo Day 2018
on 2018-04-17 as exhibitor
Official Site Inspections
http://www.nivientherapeutics.com Semrush global rank: 6.16 M Semrush visits lastest month: 1.31 K
Unable to get host informations!!!
Loading ...